Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh Class A Liver function: A Pilot Study

BACKGROUND: The present study aimed to evaluate the efficacy and safety of combined lenvatinib (first-line systemic therapy) and radiofrequency ablation (RFA) therapy in patients with intermediate-stage hepatocellular carcinoma with beyond up-to-seven criteria and Child–Pugh Class A liver function (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feiqian, Numata, Kazushi, Komiyama, Satoshi, Miwa, Haruo, Sugimori, Kazuya, Ogushi, Katsuaki, Moriya, Satoshi, Nozaki, Akito, Chuma, Makoto, Ruan, Litao, Maeda, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114706/
https://www.ncbi.nlm.nih.gov/pubmed/35600400
http://dx.doi.org/10.3389/fonc.2022.843680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114706/
https://www.ncbi.nlm.nih.gov/pubmed/35600400
http://dx.doi.org/10.3389/fonc.2022.843680

Ejemplares similares